2004
DuPont™ and Tate & Lyle enter a joint venture, DuPont Tate & Lyle Bio Products LLC, investing $100 million to commercialize a new, high performance, renewably sourced biomaterial.
DuPont™ and Tate & Lyle enter a joint venture, DuPont Tate & Lyle Bio Products LLC, investing $100 million to commercialize a new, high performance, renewably sourced biomaterial.